Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Myriad Genetics (NASDAQ: MYGN) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's management team will deliver a presentation on Wednesday, January 15, at 3:45 PM PT (6:45 PM ET).
Interested parties can access the presentation through a live webcast available in the investor relations section of Myriad's website at investor.myriad.com. For those unable to attend the live session, an archived version of the presentation will be made available on the same day.
Myriad Genetics (NASDAQ: MYGN) ha annunciato la sua partecipazione alla 43ª Conferenza Sanitaria Annuale J.P. Morgan a San Francisco. Il team di gestione dell'azienda farà una presentazione mercoledì 15 gennaio, alle 15:45 PT (18:45 ET).
Le parti interessate possono assistere alla presentazione tramite un webcast dal vivo disponibile nella sezione delle relazioni con gli investitori del sito web di Myriad all'indirizzo investor.myriad.com. Per coloro che non possono partecipare alla sessione dal vivo, una versione archiviata della presentazione sarà resa disponibile lo stesso giorno.
Myriad Genetics (NASDAQ: MYGN) ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica J.P. Morgan en San Francisco. El equipo de gestión de la empresa realizará una presentación el miércoles 15 de enero, a las 3:45 PM PT (6:45 PM ET).
Las partes interesadas pueden acceder a la presentación a través de un webcast en vivo disponible en la sección de relaciones con inversores del sitio web de Myriad en investor.myriad.com. Para aquellos que no puedan asistir a la sesión en vivo, se pondrá a disposición una versión archivada de la presentación el mismo día.
Myriad Genetics (NASDAQ: MYGN)은 샌프란시스코에서 열리는 제43회 JP모건 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 회사의 경영진은 1월 15일 수요일, 오후 3:45 PT (오후 6:45 ET)에 발표를 진행할 예정입니다.
관심 있는 분들은 Myriad의 웹사이트 투자자 관계 섹션에서 제공되는 실시간 웹캐스트를 통해 발표를 시청할 수 있습니다. 실시간 세션에 참석할 수 없는 경우, 같은 날 발표의 기록된 버전이 제공될 것입니다.
Myriad Genetics (NASDAQ: MYGN) a annoncé sa participation à la 43e Conférence Annuelle de Santé J.P. Morgan à San Francisco. L'équipe de direction de l'entreprise fera une présentation le mercredi 15 janvier, à 15h45 PT (18h45 ET).
Les parties intéressées peuvent accéder à la présentation via un webcast en direct disponible dans la section des relations investisseurs sur le site Web de Myriad à investor.myriad.com. Pour ceux qui ne peuvent pas assister à la session en direct, une version archivée de la présentation sera mise à disposition le même jour.
Myriad Genetics (NASDAQ: MYGN) hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz in San Francisco angekündigt. Das Management-Team des Unternehmens wird am Mittwoch, den 15. Januar, um 15:45 Uhr PT (18:45 Uhr ET) eine Präsentation halten.
Interessierte können die Präsentation über einen Live-Webcast abrufen, der im Bereich für Investoren auf der Website von Myriad unter investor.myriad.com verfügbar ist. Für diejenigen, die an der Live-Session nicht teilnehmen können, wird am selben Tag eine archivierte Version der Präsentation bereitgestellt.
- None.
- None.
SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15, at 3:45pm PT (6:45pm ET).
The presentation will be available through a live webcast in the investor relations section of Myriad’s website at investor.myriad.com. An archived edition of the presentation will be available later that day.
About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com
Media Contact
Glenn Farrell
(385) 318-3718
PR@myriad.com
FAQ
When is Myriad Genetics (MYGN) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Myriad Genetics' (MYGN) J.P. Morgan Healthcare Conference presentation?
Will Myriad Genetics' (MYGN) J.P. Morgan Healthcare Conference presentation be available after the event?
Which Myriad Genetics (MYGN) executives will present at the 2025 J.P. Morgan Healthcare Conference?
